Dannielle Appelhans SEC EDGAR Filings (CIK 0001874962)

SEC EDGAR filings, ownership reports, and insider transactions for Dannielle Appelhans.

Business address
C/O Rubius Therapeutics, Inc., 399 Binney Street, Suite 300, Cambridge, MA, 02139
Top holdings (ownership)
GBIO
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
Dannielle Appelhans has filed 13 SEC EDGAR filings since 16 Aug 2021

Latest Filings

Recent SEC filings for Dannielle Appelhans including 4, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 06 Jun 2025 04 Jun 2025 001-39319
4 Open 4 document View SEC filing for 4 10 Jun 2024 06 Jun 2024 001-39319
4 Open 4 document View SEC filing for 4 11 Dec 2023 08 Dec 2023 001-39319
4 Open 4 document View SEC filing for 4 06 Dec 2023 04 Dec 2023 001-39319
4 Open 4 document View SEC filing for 4 12 Jun 2023 08 Jun 2023 001-39319
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 27 Feb 2023 24 Feb 2023 001-38586
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 01 Feb 2023 31 Jan 2023 001-38586
4 Open 4 document View SEC filing for 4 FORM 4 12 Aug 2022 09 Aug 2022 001-38586
4 Open 4 document View SEC filing for 4 19 Jul 2022 15 Jul 2022 001-39319
3 Open 3 document View SEC filing for 3 19 Jul 2022 15 Jul 2022 001-39319
4 Open 4 document View SEC filing for 4 FORM 4 - 01 Feb 2022 31 Jan 2022 001-38586
4 Open 4 document View SEC filing for 4 FORM 4 - 01 Sep 2021 31 Aug 2021 001-38586
3 Open 3 document View SEC filing for 3 FORM 3 - 16 Aug 2021 09 Aug 2021 001-38586

About this filer

Dannielle Appelhans files with the SEC under CIK 0001874962. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages